Laryngeal Cancer Therapeutics - Pipeline Assessment

and Market Forecasts to 2019

On 30thDecember 2014

Summary
The industry analysis specialist, has released its new report, Laryngeal Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Laryngeal Cancer Therapeutics market. The report
identifies the key trends shaping and driving the global Laryngeal Cancer Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging
players expected to significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline products within the
global Laryngeal Cancer Therapeutics sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis by
GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-laryngeal-cancer-therapeutics-pipeline-assessment-and-marketforecasts-135234

Scope
The report provides information on the key drivers and challenges of the Laryngeal Cancer
Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Laryngeal
Cancer Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Laryngeal Cancer
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Laryngeal Cancer Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Laryngeal Cancer Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Laryngeal Cancer Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Laryngeal Cancer Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Laryngeal Cancer Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Laryngeal Cancer Therapeutics - Introduction
2.1 Disease Overview
2.2 Epidemiology
2.3 Etiology and Risk Factors
2.4 Signs and Symptoms
2.5 Diagnosis
2.6 Staging (TNM Classification)
2.7 Treatment
2.7.1 Treatment by Stage of the Disease
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.7.2 Surgery
2.7.3 Radiation Therapy
2.7.4 Chemotherapy
2.7.5 Targeted Therapy
2.8 GlobalData Pipeline Report Guidance
3 Laryngeal Cancer Therapeutics - Market Characterization
3.1 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Global
3.2 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Global
3.3 Laryngeal Cancer Therapeutics Market Size (2006-2011) - The US
3.4 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - The US
3.5 Laryngeal Cancer Therapeutics Market Size (2006-2011) - The UK
3.6 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - The UK
3.7 Laryngeal Cancer Therapeutics Market Size (2006-2011) - France
3.8 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - France
3.9 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Germany
3.10 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Germany
3.11 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Italy
3.12 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Italy
3.13 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Spain
3.14 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Spain
3.15 Laryngeal Cancer Therapeutics Market Size (2006-2011) - Japan
3.16 Laryngeal Cancer Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for Laryngeal Cancer Therapeutic Market
3.17.1 Drivers for the Laryngeal Cancer Therapeutics Market
3.17.2 Barriers for the Laryngeal Cancer Therapeutics Market
3.18 Key Events Impacting the Future Market
3.19 Opportunity and Unmet Need
3.20 Key Takeaway
4 Laryngeal Cancer Therapeutics Market - Competitive Assessment
4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Laryngeal Cancer Therapeutics - Profile for Marketed Products
4.2.1 Erbitux (cetuximab)
4.2.2 Taxotere (docetaxel)
4.2.3 Bleomycin
4.3 Key Takeaway
5 Laryngeal Cancer Therapeutics Market - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

5.3 Laryngeal Cancer Pipeline Analysis - Pipeline by Phases of Development

5.3.1 Laryngeal Cancer Therapeutics - Phase III Pipeline
5.3.2 Laryngeal Cancer Therapeutics - Phase II Pipeline
5.3.3 Laryngeal Cancer Therapeutics - Phase I/II Pipeline
5.3.4 Laryngeal Cancer Therapeutics - Phase I Pipeline
5.4 Laryngeal Cancer Pipeline by Mechanism of Action
5.5 Laryngeal Cancer Technology Trends Analytical Framework
5.6 Laryngeal Cancer Therapeutics - Profile for Late Stage Molecules
5.6.1 Bevacizumab
5.6.2 Panitumumab
5.6.3 S-1
5.7 Key Takeaway
6 Laryngeal Cancer Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials Mapping by Region/Country
6.2 Clinical Trials Mapping by Phase
6.3 Clinical Trials Mapping by Trial Status
6.4 Clinical Trials Mapping by Overall Sponsors
6.5 Clinical Trial Mapping by Prominent Sponsors
7 Laryngeal Cancer Therapeutics - Strategic Assessment
7.1 Future Market Competition Scenario
8 Laryngeal Cancer Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Amgen Inc.
9 Global Laryngeal Cancer Therapeutics Market - Appendix
9.1 Definitions
9.2 Acronyms
9.3 Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Forecasting
9.3.4 Primary Research
9.3.5 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Bibliography

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

List Of Tables
Table 1: Laryngeal Cancer - Epidemiology 2010
Table 2: Stage Distribution and Five-year Relative Survival by Stage at Diagnosis for 2001-2007
Table 3: Laryngeal Cancer , TNM Definitions
Table 4: Laryngeal Cancer - Anatomic Stage/Prognostic Groups and Development of Cancer
Cells
Table 5: Laryngeal Cancer Treatment Options by Stages
Table 6: Laryngeal Cancer - Chemotherapy with Radiation Therapy for Locally Advanced Stages
(Stage III - IVB)
Table 7: Laryngeal Cancer - Induction Chemotherapy for Locally Advanced Stages III-IVB
Table 8: Laryngeal Cancer - First-Line Chemotherapy for Metastatic or Recurrent Stage IVC
Table 9: Laryngeal Cancer , Second and Third-Line Chemotherapy for Metastatic or Recurrent
Stage (Stage IVC)
Table 10: Laryngeal Cancer Therapeutics, Global, Market Revenue ($m), 2006-2011
Table 11: Laryngeal Cancer Therapeutics, Global, Forecast ($m), 2011-2019
Table 12: Laryngeal Cancer Therapeutics, The US, Market Revenue ($m), 2006-2011
Table 13: Laryngeal Cancer Therapeutics, The US, Forecast ($m), 2011-2019
Table 14: Laryngeal Cancer Therapeutics, The UK, Market Revenue ($m), 2006-2011
Table 15: Laryngeal Cancer Therapeutics, The UK, Forecast ($m), 2011-2019
Table 16: Laryngeal Cancer Therapeutics, France, Market Revenue ($m), 2006-2011
Table 17: Laryngeal Cancer Therapeutics, France, Forecast ($m), 2011-2019
Table 18: Laryngeal Cancer Therapeutics, Germany, Market Revenue ($m), 2006-2011
Table 19: Laryngeal Cancer Therapeutics, Germany, Forecast ($m), 2011-2019
Table 20: Laryngeal Cancer Therapeutics, Italy, Market Revenue ($m), 2006-2011
Table 21: Laryngeal Cancer Therapeutics, Italy, Forecast ($m), 2011-2019
Table 22: Laryngeal Cancer Therapeutics, Spain, Market Revenue ($m), 2006-2011
Table 23: Laryngeal Cancer Therapeutics, Spain, Forecast ($m), 2011-2019
Table 24: Laryngeal Cancer Therapeutics, Japan, Market Revenue ($m), 2006-2011
Table 25: Laryngeal Cancer Therapeutics, Japan, Forecast ($m), 2011-2019
Table 26: Laryngeal Cancer Therapeutics - Phase III Pipeline, 2011
Table 27: Laryngeal Cancer Therapeutics - Phase II Pipeline, 2011
Table 28: Laryngeal Cancer Therapeutics - Phase I/II Pipeline, 2011
Table 29: Laryngeal Cancer Therapeutics - Phase I Pipeline, 2011
Table 30: Laryngeal Cancer Therapeutics - Clinical Mapping by Region/Country, 2011
Table 31: Laryngeal Cancer Therapeutics - Clinical Mapping by Phase, 2011
Table 32: Laryngeal Cancer Therapeutics - Clinical Mapping by Trial Status, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 33: Laryngeal Cancer Therapeutics - Clinical Mapping by Overall Sponsors, 2011
Table 34: Laryngeal Cancer Therapeutics - Clinical Mapping by Prominent Sponsors, 2011
Table 35: Amgen - Molecule in the Pipeline for Head and Neck Cancer, 2011

List Of Figures
Figure 1: Laryngeal Cancer - Disease Characterization
Figure 2: Laryngeal Cancer Therapeutics, Global, Market Revenue ($m), 2006-2011
Figure 3: Laryngeal Cancer Therapeutics, Market Share ($m, %), 2011
Figure 4: Laryngeal Cancer Therapeutics, Global, Forecast ($m), 2011-2019
Figure 5: Laryngeal Cancer Therapeutics, Market Share ($m, %), 2019
Figure 6: Laryngeal Cancer Therapeutics, The US, Market Revenue ($m), 2006-2011
Figure 7: Laryngeal Cancer Therapeutics, The US, Forecast ($m), 2011-2019
Figure 8: Laryngeal Cancer Therapeutics, The UK, Market Revenue ($m), 2006-2011
Figure 9: Laryngeal Cancer Therapeutics, The UK, Forecast ($m), 2011-2019
Figure 10: Laryngeal Cancer Therapeutics, France, Market Revenue ($m), 2006-2011
Figure 11: Laryngeal Cancer Therapeutics, France, Forecast ($m), 2011-2019
Figure 12: Laryngeal Cancer Therapeutics, Germany, Market Revenue ($m), 2006-2011
Figure 13: Laryngeal Cancer Therapeutics, Germany, Forecast ($m), 2011-2019
Figure 14: Laryngeal Cancer Therapeutics, Italy, Market Revenue ($m), 2006-2011
Figure 15: Laryngeal Cancer Therapeutics, Italy, Forecast ($m), 2011-2019
Figure 16: Laryngeal Cancer Therapeutics, Spain, Market Revenue ($m), 2006-2011
Figure 17: Laryngeal Cancer Therapeutics, Spain, Forecast ($m), 2011-2019
Figure 18: Laryngeal Cancer Therapeutics, Japan, Market Revenue ($m), 2006-2011
Figure 19: Laryngeal Cancer Therapeutics, Japan, Forecast ($m), 2011-2019
Figure 20: Laryngeal Cancer Therapeutics, Key Events Impacting the Future Market, 2011
Figure 21: Opportunity and Unmet Need in the Laryngeal Cancer Therapeutics Market, 2011
Figure 22: Laryngeal Cancer Therapeutics, Strategic Competitor Assessment, 2011
Figure 23: Laryngeal Cancer Therapeutics - Pipeline by Phase of Development, 2011
Figure 24: Laryngeal Cancer Market - Clinical Pipeline by Mechanism of Action, 2011
Figure 25: Technology Trends Analytical Framework of the Laryngeal Cancer Pipeline, 2011
Figure 26: Technology Trends Analytical Framework of Laryngeal Cancer Pipeline - Description,
2011
Figure 27: Laryngeal Cancer Therapeutics - Clinical Mapping by Region/Country, 2011
Figure 28: Laryngeal Cancer Therapeutics - Clinical Mapping by Phase, 2011
Figure 29: Laryngeal Cancer Therapeutics - Clinical Mapping by Trial Status, 2011
Figure 30: Laryngeal Cancer Therapeutics - Clinical Mapping by Overall Sponsors, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 31: Laryngeal Cancer Therapeutics - Clinical Mapping by Prominent Sponsors, 2011
Figure 32: Laryngeal Cancer Therapeutics, Strategic Assessment, 2011
Figure 33: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019
Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Laryngeal Cancer Therapeutics - Pipeline Assessment and

Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-laryngeal-cancertherapeutics-pipeline-assessment-and-market-forecasts-135234

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/